Irokid 50/5 Syrup
Iron Hydroxide Polymaltose
50mg/5ml
Medpharma Pharma. & Chem. Ind's (L.L.C)
| Pack size | 100ml Glass Bottle |
|---|---|
| Dispensing mode | POM |
| Source | UAE |
| Agent | ARABIAN ETHICALS CO. |
| Retail Price | 14.50 AED |
Indications
Irokid 50/5 Syrup is used for:
Iron-deficiency anemia
Adult Dose
Dosage and duration of therapy are dependent upon the extent of iron deficiency.
Adults: 10 ml once or twice daily
Child Dose
Dosage and duration of therapy are dependent upon the extent of iron deficiency.
Children (6 - 12 years): 10 ml daily
Children (2 - 6 years): 5 ml daily
Premature infants & Infants: 3.33 mg of elemental iron/kg body weight (0.06 ml drops/kg body weight) daily.
Renal Dose
Administration
Contra Indications
Hypersensitivity or intolerance to iron and overloading of iron in the body. Anaemia not caused by iron deficiency. Disturbances in iron utilisation, thalassemia. Patients receiving repeated blood transfusion. Parenteral: Iron overload, Ostler-Rendu-Weber syndrome, chronic polyarthritis, bronchial asthma, inflammation or infection of kidney or liver, uncontrolled hyperparathyroidism, decompensated liver cirrhosis. Pregnancy (1st trimester).
Precautions
Avoid concomitant parenteral and oral iron admin, oral iron therapy should start at least 1 wk after last iron inj. Parenteral: Pregnancy (2nd and 3rd trimester), allergies, hepatic and liver insufficiency, low iron binding capacity and or folic acid deficiency. Facilities for CPR should be available during admin. Excessive IV infusion rate may cause nausea and epigastric upset. IV infusion route should be used only if IM route is unacceptable and when there is no stored iron in the bone marrow.
Pregnancy-Lactation
Interactions
Concurrent use with psychotropic drugs may worsen constipation. Increased systemic side effects with concomitant ACE inhibitors and parenteral iron admin.
Adverse Effects
Side effects of Iron Hydroxide Polymaltose :
GI irritation, epigastric pain, stomach cramping, constipation, nausea, vomiting, diarrhoea, dark stools, heart burn, discoloured urine, teeth staining. IM: pain at inj site, abdominal pain at lower quadrant and local inflammation with inguinal lymphadenopathy. IV: Joint and muscle pain, bronchospasm, hypotension, tachycardia, flushing, sweating, dizziness.
Potentially Fatal: Parenteral: Anaphylactoid reactions, circulatory collapse.
Mechanism of Action
Iron polymaltose is a water soluble, macro-molecular complex of iron (III) hydroxide and isomaltose. It is used in the treatment of iron-deficiency anaemia.
Note
Irokid 50/5 50mg/5ml Syrup manufactured by Medpharma Pharma. & Chem. Ind's (L.L.C). Its generic name is Iron Hydroxide Polymaltose. Irokid 50/5 is availble in United Arab Emirates.
Farmaco UAE drug index information on Irokid 50/5 Syrup is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.